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Abstract
Background: Peri-implantitis is known as an infectious disease that affects the peri-implant soft and hard tissue. Today,
scientific literature provides very little evidence for an effective intervention protocol for treatment of peri-implantitis.
The aim of the present randomized controlled trial is to evaluate the microbiological and clinical effectiveness of
phosphoric acid as a decontaminating agent of the implant surface during surgical peri-implantitis treatment.
Methods: Peri-implantitis lesions were treated with resective surgical treatment aimed at peri-implant granulation
tissue removal, bone recontouring, and pocket elimination. Fifty-three implant surfaces in 28 patients were
mechanically cleaned and treated with either 35% phosphoric etching gel (test group) or sterile saline (control group).
Microbiological samples were obtained during surgery; clinical parameters were recorded at baseline and at 3 months
after treatment. Data were analyzed using multi-variable linear regression analysis and multilevel statistics.
Results: Significant immediate reductions in total anaerobic bacterial counts on the implant surface were
found in both groups. Immediate reduction was greater when phosphoric acid was used. The difference in
log-transformed mean anaerobic counts between both procedures was not statistical significant (p = 0.108),
but there were significantly less culture-positive implants after the decontamination procedure in the
phosphoric acid group (p = 0.042). At 3 months post-surgery, 75% of the implants in the control group and
63.3% of the implants in the test group showed disease resolution. However, no significant differences in
clinical and microbiological outcomes between both groups were found.
Conclusions: The application of 35% phosphoric acid after mechanical debridement is superior to mechanical
debridement combined with sterile saline rinsing for decontamination of the implant surface during surgical
peri-implantitis treatment. However, phosphoric acid as implant surface decontaminant does not seem to
enhance clinical outcomes on a 3-month follow-up.
Trial registration: Netherlands National Trial Register, NTR5185 (www.trialregister.nl)
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Background
Triggered host defense responses initiate inflammation
of the peri-implant soft tissue (peri-implant mucositis),
which can lead to loss of peri-implant supporting bone
(peri-implantitis), and eventually, result in implant fail-
ure [1]. An increasing prevalence of peri-implantitis has
been described in recent literature [2], with current inci-
dence ranging from 1 to 47%. A non-linear, accelerating
pattern of progress is suggested for the majority of cases,
with an occurring onset within 3 years of function [3].
As for periodontal disease, the presence of micro-
organisms is an important factor for the development of
an inflammatory response in peri-implant tissue [4]. In
order to effectively treat the peri-implant inflammation,
disruption of microbial adhesion and reduction of bio-
film accumulation on the implant surface is probably of
eminent importance.
A number of mechanical interventions (e.g., abrasive
air powder, teflon curettes, ultrasonic devices) and
chemical agents (e.g., chlorhexidine, hydrogen peroxide)
solely or in combination have been described as methods
for implant surface decontamination in both in vivo and
in vitro studies, in both a surgical and non-surgical
setting ([5–12]). According to different reviews on in
vivo and in vitro mechanical debridement [13–17], a
gold standard mechanical debridement regimen still
does not exists. Possibly, the implant surface roughness
and screw-shaped design of dental implants may com-
promise an effective mechanical intervention. Therefore,
the additional use of chemical agents for implant decon-
tamination may be advocated.
Antimicrobial solutions have been studied in different
clinical studies [9, 10, 18, 19]. No superior clinical
effectiveness has been shown in a single study for a spe-
cific chemical decontamination protocol (for reviews see
[17, 20, 21]). However, studies using acids at low pH
(<2) have shown potentially beneficial antiseptic effects
[22–29]. Especially, results on decontamination with
phosphoric acid might be promising. Wiltfang et al. [27]
showed that surface decontamination with phosphoric
acid (pH 1) in a surgical treatment protocol resulted in
complete elimination of the bacterial microflora. Also,
results of a short-term clinical trial by Strooker et al.
[26] showed an instant greater reduction of colony-
forming units on the implant surface when using phos-
phoric etching gel (pH 1). In addition, animal studies
[30, 31] showed re-osseointegration and direct bone-to-
implant contact when acids were used. Therefore, phos-
phoric acids might be considered a potentially feasible
decontaminating agent.
Thus far, the use of phosphoric acid etching gel as
decontaminating agent has not been evaluated in a
randomized controlled trial. The aim of the present ran-
domized controlled trial is to evaluate the short-term
microbiological and clinical effectiveness of 35% phos-
phoric etching gel as a decontaminating agent of the




The present study is a double-blind randomized con-
trolled trial evaluating the effect of 35% phosphoric etch-
ing gel (test group) compared to the effect of saline
(control group) for implant surface decontamination
combined with mechanical debridement during surgical
peri-implantitis treatment. Patients were randomly
assigned to the test or control group using a one-to-one
allocation ratio. The study has been conducted in full
accordance with the World Medical Association Declar-
ation of Helsinki (version 2008) and was approved by
the Institutional Review Board of the University Medical
Center Groningen, the Netherlands (METc2013.005).
Written informed consent was obtained from all partici-
pants before entering the trial. Clinical trial registration
was done at the Netherlands National Trial Register
(http://www.trialregister.nl, trial number NTR5185). The
CONSORT guidelines for reporting a clinical trial were
followed.
Participants
Patients participating in this study were consecutively
selected from the patient populations of the Center of
Dentistry and Oral Hygiene and the Department of Oral
and Maxillofacial Surgery of the University Medical
Center Groningen, Groningen, The Netherlands, from
October 2012 to April 2014.
Adult patients with at least one endosseous implant
with clinical and radiographical signs of peri-implantitis
were included. Peri-implantitis was defined as a loss of
marginal bone ≥2 mm in combination with bleeding
and/or suppuration on probing and a peri-implant prob-
ing depth ≥5 mm [32]. Implants had to be in function
for at least 2 years.
Exclusion criteria were:
 Contraindications for the surgical procedures;
 A history of local radiotherapy to the head and neck
region;
 Pregnancy and lactation;
 Uncontrolled diabetes;
 Systemic use of antibiotics within 3 months before
inclusion;
 Long-term use of anti-inflammatory drugs;
 Incapability of performing basal oral hygiene
measures as a result of physical or mental disorders;
 Uncontrolled periodontitis (PPD >5 mm);
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 Implants with bone loss exceeding two thirds of the
length of the implant or implants with bone loss
beyond the transverse openings in hollow implants;
 Implant mobility;
 Implants at which no position could be identified
where proper probing measurements could be
performed;
 Previous surgical treatment of the peri-implantitis
lesions.
Interventions
The study protocol was based on the study protocols of
two previous studies evaluating the decontaminating ef-
fect of chlorhexidine during surgical peri-implantitis
treatment [10, 32] and is briefly described below.
Within 1 month before surgical treatment, all patients
received extensive oral hygiene instructions and mechan-
ical non-surgical debridement of implants and remaining
dentition using hand instrumentation and/or an ultrasonic
device. Immediately before surgical treatment screw-
retained suprastructures were removed. In order to obtain
an optimal overview of the peri-implant area during
surgery, prior to the procedure, only screw-retained
suprastructures were removed. Cemented single crowns
or bridges on mesostructures were left in place to prevent
any damage to these structures. Directly after surgery, the
screw-retained suprastructures were placed back. Cemen-
ted single crowns or bridges on mesostructures were left
in place to prevent any damage to these structures. Verti-
cal releasing incisions extending into the alveolar mucosa
were placed using a surgical blade (no. 15), and full thick-
ness mucoperiosteal flaps were raised buccally and lin-
gually. Flaps were designed to allow optimal access to the
peri-implant bone defect. Granulation tissue was removed
using titanium curettes (Gracey; Hu-Friedy®, Chicago, IL,
USA). The implant surfaces were mechanically cleaned
using titanium curettes and gauzes and cotton pellets
soaked in saline. Next, the patients were randomly allo-
cated to either the test or control group. Subsequently,
implants were cleaned with either local application of 35%
phosphoric acid gel (pH 1) for 1 min (Temrex gel,
Temrex, Freeport, NY, USA) (test group) or by rinsing
with an abundant amount of sterile saline for 1 min
(control group). Care was taken to apply the phosphoric
etching gel precisely on the implant surface using a syr-
inge with a small tip. During 1 min, the etching gel was
continuously rubbed on to the implant surface with a
small brush. In both groups, the intervention continued
with rinsing of the implant surface with an abundant
amount of sterile saline for 1 min.
Angular bony defects were eliminated, and bone was
recontoured using a rotating round bur under saline irri-
gation. Mucosal flaps were apically positioned and firmly
sutured (Vicryl Plus® 3-0; Ethicon Inc., Somerville, NJ,
USA), and suprastructures were re-positioned. For both
control and test group, surgery was followed by 2 weeks
of mouth rinsing with 0.12% CHX + 0.05% CPC without
alcohol two times daily for 30 s. Sutures were removed
after 2 weeks. Follow-up visits were scheduled after 3
(T3) months. Patients were all surgically treated by one
experienced oral and maxillofacial surgeon (GR).
Outcomes
Primary outcome variable
The primary outcome variable was the difference in an-
aerobic bacterial load of the implant surface before and
after mechanical and chemical debridement and decon-
tamination. After flap deflection and granulation tissue
removal, a sample was obtained from the implant sur-
face by rubbing a sterilized brush (Microbrush® Inter-
national, Grafton, WI, USA) across the implant surface
(Tpre). A second sample was obtained after mechanical
debridement, decontamination of the implant surface
with the test or control substance, and subsequent rins-
ing with sterile saline (Tpost). After sampling, the top
part of the brush was cut off and collected in a vial con-
taining reduced transport fluid [33]. From every implant
presenting peri-implantitis, separate samples were
obtained. All microbiological samples were processed
within 24 h [34]. The total anaerobic bacterial load and
the presence and numbers of the periodontal pathogens
[35] Aggregatibacter actinomycetemcomitans, Porphyro-
monas gingivalis, Prevotella intermedia, Tannerella
forsythia, Fusobacterium nucleatum, Parvimonas micra,
and Campylobacter rectus were determined by labora-
tory technicians who were blind to treatment allocation.
Secondary outcome variables
Secondary outcome variables were percentage of sites
with bleeding on probing (% sites BoP), percentage of
sites with suppuration on probing (% sites SoP), mean
probing pocket depth (mean PPD), and microbial com-
position of the peri-implant sulcus. Measurements were
performed before (pre) treatment (baseline, T0) and at
3 months (T3) after surgery by one and the same exam-
iner (DH) who was blind to treatment allocation. Peri-
implant pocket depth was measured at four sites per
implant (mesial, buccal, distal, and lingual) using a pres-
sure sensitive probe (KerrHawe Click Probe®, Bioggo,
Switzerland) (probe force of 0.25 N). Bleeding and sup-
puration were scored up to 30s after pocket probing.
Microbiological peri-implant sulcus samples were col-
lected from each implant with peri-implantitis using four
sterile paperpoints per implant. Paperpoints were collected
in a vial containing RTF and were analyzed in the same
manner as the intra-operative samples. Outcome variables
were total anaerobic bacterial load and the presence and
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numbers of the periodontal pathogens A. actinomycetem-
comitans, P. gingivalis, P. intermedia,T. forsythia, F. nucle-
atum, P. micra, and C. rectus.
Randomization
Fourteen notes with the word “phosphoric acid” and 14
notes with the word “saline” were put into 28 identical,
sequentially numbered, non-transparent envelopes ac-
cording to a randomization list generated by a computer
program. The envelopes were irreversibly sealed. During
the surgical procedure, after flap deflection and mechan-
ical cleansing, the surgeon temporarily left the operating
room. The surgical assistant opened an envelope and
prepared the materials as needed according to the infor-
mation on the note. A third person (YDW) performed
the decontamination procedure according to group allo-
cation. The materials were removed, and the surgeon
continued the surgical procedure. The researcher (per-
forming the clinical measurements, DH) was blind to
treatment allocation and did not have access to the
randomization code until the end of the research period.
Statistical methods
Sample size
Sample size was based on the microbiological data from a
previous study evaluating the effect of implant surface
decontamination with a chlorhexidine solution versus a
placebo solution [10]. The decontaminating effect of phos-
phoric acid was expected to be similar to the decontamin-
ating effect of chlorhexidine (reduction in log-transformed
mean anaerobic bacterial load = 4.21 (chlorhexidine
group) versus 2.77 (placebo group), SD = 2.12). Assuming
a two-sided two sample t test with a significance level (α)
of 0.05 and a power (β) of 80% required a sample size of
34 implants. A 20% compensation for dropouts was taken
into account (34/0.8 = 42.5 implants). Based on a previous
study [10], it was expected that not all baseline microbio-
logical samples would yield a detectable number of cultiv-
able bacteria ([10], 19 out of 79 = 24% of samples showed
no bacterial growth). Because “negative” samples cannot
be used to determine a decontaminating effect, the sample
size was compensated for these potential unusable sam-
ples (24%), yielding a sample size of 56 implants (42.5/
0.76). According to the assumption that each patient has
on average more than two implants with peri-implantitis
[10], a sample size of 28 patients was chosen (56/2, 14 pa-
tients per group).
Statistical analysis
For the analysis of the primary outcome variable and the
secondarymicrobiological outcome variable linear regression
analysis was performed. The implant was taken as the statis-
tical unit. Total anaerobic bacterial loads at baseline (Tpre
and T0) were distributed normally after logarithmic
transformation. Baseline values were included in the regres-
sion model. For the comparison of the number of culture-
positive implants after the decontamination period, the chi-
square test was used. The secondary clinical outcome
variables were analyzed using a two-level hierarchical
random intercepts model. The two levels of analysis were
implant level and patient level. With the crude analysis, the
effect of the intervention was determined, while controlling
for baseline value. Because a previous study [9] has shown
that mean bone loss at baseline and smoking are prognostic
indicators for the outcome of resective peri-implantitis treat-
ment, these factors were additionally included in the model
(adjusted analysis).
Descriptive data and data regarding the microbio-
logical outcome variables were analyzed using IBM SPSS
Statistics 22 Version 22.0 (IBM Corp. Armonk, NY: IBM
Corp.). Multilevel models were analyzed using MLwiN
version 2.12 (Centre for Multilevel Modeling, University
of Bristol, Bristol, UK).
Results
The progress of patients throughout the different phases
of the study is illustrated in Fig. 1. Table 1 depicts the
baseline demographic patient and implant characteris-
tics. The included patients had a total of 128 implants of
which 53 implants showed signs of peri-implantitis.
Different implant brands and types with different
implant surfaces were present, including Straumann
(Straumann AG, Basel, Switserland; SLA® and SLActive®
surface), Nobel Biocare (Nobel Biocare AB, Göteborg,
Sweden; TiUnite® surface), Biomet 3i (Biomet Inc., Warsaw,
Indiana, USA; OSSEOTITE® surface), Frialit-2, (Dentsply
Friadent, Mannheim, Germany; FRIADENT® plus sur-
face), and Pitt-Easy (Sybron Implant Solutions GmbH,
Bremen, Germany; Puretex® surface). Three patients
with each one implant with peri-implantitis were lost
to follow-up (2 patients from the control group, 1
from the test group).
Microbiological outcomes
10Log-transformed mean bacterial anaerobic counts of
the culture-positive implants for the control and test
group before and after debridement and decontamin-
ation of the implant surface during the surgical proced-
ure are depicted in Table 2. In both groups, the
debridement and decontamination procedure resulted in
a significant immediate reduction in counts of anaerobic
bacteria on the implant surface. Although the reduction
in total anaerobic load was greater in the test group, the
difference did not reach the level of statistical signifi-
cance (p = 0.108). However, in the test group, the total
anaerobic load was significantly more often reduced
below detection level than in the control group (20 out
of 23 in the test group, 10 out of 17 in the control
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group, p = 0.042). No significant differences were ob-
served in the 10Log-transformed mean bacterial anaer-
obic counts of the peri-implant sulcus, neither between
control and test group nor between baseline and
3 months after surgery (Table 3).
Clinical outcomes
Descriptive statistics of the clinical outcomes at baseline
and follow-up are depicted in Table 4. At 3-month
follow-up, 75% of the implants (66.7% of the patients) in
the control group and 63.3% of the implants (53.8% of
the patients) in the test group showed no clinical signs
of inflammation (PPD ≤4 mm without bleeding and/or
suppuration on probing) (Table 4). The results from the
multilevel analyses regarding the effects of the interven-
tion on BoP, SoP, and PPD are shown in Table 5. No sig-
nificant differences in BoP, SoP, and mean PPD were
detected between control and test group at 3 months
after surgery, neither in the “crude” nor in the “adjusted”
analysis.
Discussion
This randomized controlled trial aimed to determine the
effect of 35% phosphoric etching gel on decontamination
of the implant surface during resective surgical treatment
of peri-implantitis. Both decontamination procedures
(mechanical debridement with curettes and gauzes com-
bined with phosphoric acid 35% and mechanical
Fig. 1 Flow diagram
Table 1 Characteristics of included patients/implants
Characteristics Control Test
Number of patients 14 14
Age (years; mean [SD]) 57.0 (13.7) 60.9 (7.2)
Gender; M (male), F (female) M5, F9 M7, F7
Smoking; n subjects (%) 1 (7%) 3 (21%)
History of periodontitis; n subjects (%) 4 (29%) 5 (36%)
Dental status; n subjects (%)
- Partially edentulous 13 (93%) 12 (86%)
- Fully edentulous 1 (7%) 2 (14%)
Total number of implants (range) 68 (1–9) 60 (1–10)
Number of implants with peri-implantitis (range) 22 (1–4) 31 (1–5)
Mean bone loss at baseline in mm (SD) 2.73 (1.49) 3.58 (1.57)
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debridement combined with sterile saline) resulted in a
significant immediate reduction in counts of anaerobic
bacteria on the implant surface. This immediate reduction
was greater when phosphoric acid was used. Although the
difference in log-transformed mean anaerobic counts be-
tween both decontaminating procedures did not reach the
level of statistical significance (p = 0.108), there were sig-
nificantly less culture-positive implants after the decon-
tamination procedure in the phosphoric acid group (p =
0.042). As our study focused on the decontaminating ef-
fect of phosphoric acid on implant surfaces, we used the
microbiological parameter as primary outcome variable.
To evaluate the effect of the intervention on this micro-
biological parameter, an in vivo situation was chosen to
benefit the influence of a clinical situation. In addition, we
evaluated secondary outcome parameters indicating the
clinical effect of the treatment procedure, i.e., disease reso-
lution 3 months after active treatment.
At 3 months post-surgery, disease resolution was more
frequently observed in the control group (75% of
implants) than in the test group (63.3% of implants).
However, no significant differences in clinical and micro-
biological outcomes between control and test group
were found. Although the study was “a priori” not pow-
ered to detect clinical differences, no trend was observed
for superior results of one decontamination procedure
over the other.
To our knowledge, this is the first randomized con-
trolled clinical trial reporting on the effect of phosphoric
acid in relation to peri-implantitis treatment. The reason
for choosing phosphoric acid as decontaminating agent
was that acids with low pH exert a strong bactericidal
effect [22, 36], and phosphoric acid does not seem to
chemically damage titanium implant surface [37]. A gel
as application mode has the great advantage of being
precisely applicable with minimal touching of the sur-
rounding bone or connective tissue. A disadvantage of a
gel might be the limited flow in deeper areas of the
rough implant surface. To overcome this problem, it was
decided to continuously rub the etching gel onto the im-
plant surface with a small brush during the decontamin-
ation period.
Phosphoric acid gel as agent for implant surface
decontamination has only been investigated in two other
clinical studies [26, 27]. Strooker et al. [26] used phos-
phoric acid 35% for peri-implant supportive therapy and
found greater reductions in bacterial load, but no signifi-
cant clinical differences compared to conventional
mechanical supportive therapy. They concluded that
local application of 35% phosphoric acid gel can be as
effective as conventional mechanical therapy in the pro-
fessional supportive care of oral implants. In the study
of Wiltfang et al. [27], 20% etching gel was used for im-
plant surface decontamination in a combined surgical
protocol for treatment of peri-implantitis. Thirty-six im-
plants with peri-implantitis in 22 patients were followed
for 1 year. The implants were decontaminated with etch-
ing gel, and the defects were filled with autologous bone
mixed with an osteoinductive material for regenerative
treatment of bone defects. In their study, previous micro-
biological tests (not published) of implants in situ had re-
vealed complete elimination of the bacterial microflora
after decontamination with etching gel, which is close to
our results of “complete” elimination (reduction below de-
tection level) in 20 out of 23 implants. They concluded that
their surgical protocol in combination with phosphoric
etching gel provides a reliable method to treat peri-implant
bone defects.
Phosphoric acid used in an in vitro setting has only
been described in a study by Tastepe et al. [37]. The use
Table 2 Log-transformed mean bacterial anaerobic counts (SD) of culture-positive implants for the control and test group before
(Tpre) and after (Tpost) debridement and decontamination of the implant surface (intra-operative microbrush samples)
N = 40a Total anaerobic bacterial load
Log-transformed mean (SD)
Tpre Tpost Difference β (95% CI)b p value
Control 5.57 (0.93) [17] 2.25 (2.98)c [7]d 2.68 (3.25) −1.39 (−3.09–0.32) 0.108
Test 5.35 (0.98) [23] 0.81 (2.25)c [3]d 4.19 (3.31)
SD standard deviation, [n] number of culture-positive implants
aImplants with baseline values of 0 excluded from analysis
bLinear regression analysis, adjusted for baseline values
cSignificant difference from baseline
dSignificant difference in number of culture-positive implants after decontamination between test and control group (p = 0.042)
Table 3 Log-transformed mean bacterial anaerobic counts (SD)
for the control and test group before (T0) and 3 months after
(T3) the surgical treatment (paperpoint samples)
N = 47a Total anaerobic bacterial load
Log-transformed mean (SD)
T0 T3 Difference β (95% CI)b p value
Control 6.69 (1.32) 6.31 (1.30) 0.38 (1.36) −0.26 (−0.84–0.33) 0.377
Test 6.53 (1.06) 5.98 (0.94) 0.55 (0.99)
SD standard deviation
aThree samples without bacterial growth and three samples without follow-up
excluded from analysis
bLinear regression analysis, adjusted for baseline values
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of an air abrasive device with four different powders was
compared to phosphoric acid. In contrast to our study
and the previous described clinical studies, the use of
phosphoric acid was not efficient in removing biofilm.
The residual biofilm area was significantly greater after
treatment with phosphoric acid compared to air abrasive
treatment with powder or even control treatment with-
out powder. Apparently, only water and air might be
effective in reducing the biofilm. Nonetheless, when the
titanium surface was viewed under a scanning electron
microscopy (SEM), no visible titanium surface change
was seen after phosphoric acid application while some
minor changes (dependent on the character and size of
the particles) were observed after air powder abrasive
treatment.
Recent studies that zoom in on titanium surface
physico-chemistry reveal interesting results [38, 39].
Kotsakis et al. [38] hypothesized that chemical residues
alter the titanium surface physicochemistry and subse-
quently compromise cellular response to these decontami-
nated surfaces. However, they report on effective restoring
of biocompatibility when sterile saline, citric acid, and
EDTA/sodium hypochlorite (NaOCl-EDTA) were used, in
contrast to chlorhexidine. Therefore, they propose the use
of sterile saline, citric acid, and NaOCl-EDTA in the treat-
ment of peri-implantitis not only for their antimicrobial
properties but also for the preservation of the titanium
material properties. In contrast, a study by [39] found
noticeable morphological changes and corrosion on
the titanium surface when the synergistic effect of
acidic environments (i.e., citric acid, 15% hydrogen
peroxide, tetracycline, peroxyacetic acid) and mechanical
forces (rubbing with cotton swabs) was investigated.
Dissolution of the oxide layer (which can result in
corrosion) was observed when using peroxyacetic and
citric acid. It is therefore hypothesized that surface
damage of dental alloys may potentially be induced
after detoxification and maintenance treatments with
acidic solutions and subsequently might hinder re-
osseointegration. No visibly evident damage of the
surfaces was shown by [39] when neutral or basic
treatments such as sodium fluoride 0.12, 0.20, and
1.10% were used, which might be explained by the
neutral electrochemical environment [40].
Table 4 Descriptive statistics of clinical parameters
Control Test
T0 (n = 22) T3 (n = 20) T0 (n = 31) T3 (n = 30)
Plaque % of sites (SD)









BoP % of sites (SD)









SoP % of sites (SD)









Mean PPD Mean (SD) 5.3 (1.1) 3.5 (1.5) 5.2 (1.1) 4.1 (1.6)
PPD ≥5 mm % of sites (SD)









PPD ≥6 mm % of sites (SD)









PPD ≥5 mm+ BoP/SoP (same site) % of sites (SD)
% of implants (n)













PPD ≥6 mm+ BoP/SoP (same site) % of sites (SD)
% of implants (n)













Table 5 Average differences in BoP, SoP, and PPD between the control and test group at 3-month follow-up
Outcome variable Crude modela
β (95% CI)






16.2 (−7.9 to 40.3)
0.0 (−10.9 to 10.9)




7.9 (−16.4 to 32.3)
0.7 (−10.1 to 11.4)




The reference category for intervention effect is the control group. The regression coefficients (β) indicate the average differences in clinical outcomes between
the control and test group at 3-month follow-up
BoP bleeding on probing, SoP suppuration on probing, PPD probing pocket depth, 95% CI 95% confidence interval
aAdjusted for baseline values
bAdjusted for baseline values, smoking, and mean bone loss at baseline
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Interpreting the results of these in vitro studies has to
be done cautiously since the results among the studies
are not homogenous and the effects of the chemical
environment coupled with mechanical force in the oral
environment has to be further evaluated. In our study,
however, phosphoric acid neither seemed to have a posi-
tive nor a negative effect on clinical outcomes.
The current study is based on a follow-up time of
3 months and therefore the long-term results on the use
of phosphoric acid remain unclear.
Conclusions
Implant surface decontamination is considered a highly
susceptible step in the treatment of peri-implantitis. The
application of 35% phosphoric acid after mechanical
debridement is superior to mechanical debridement com-
bined with sterile saline rinsing for decontamination of
the implant surface during surgical peri-implantitis treat-
ment. However, phosphoric acid as implant surface
decontaminant does not seem to enhance clinical out-
comes on a 3-month follow-up. Larger studies with a lon-
ger follow-up period are needed to validate these findings.
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